Tempest Therapeutics
Development-stage biotechnology company.
Launch date
Employees
Market cap
CAD49.8m
Enterprise valuation
CAD35m (Public information from Sep 2024)
Share price
$1.41 TPST
San Francisco California (HQ)
Authorizing premium user...